2023 USCAST Virtual Public Meeting
USCAST held a virtual meeting on February 8, 2023, and over 200 attendees joined to hear about the vision and future goals for USCAST and the 2023 in vitro susceptibility test interpretive criteria (STIC, also known as susceptibility breakpoints) recommendations. STIC were reviewed for piperacillin/tazobactam against Enterobacterales and Pseudomonas aeruginosa, various agents against A. baumannii, and aminoglycosides against Enterobacterales and P. aeruginosa.
These USCAST STIC recommendations are now open for public comment for the next 60 days. This open public comment period will end on April 30, 2023.
USCAST encourages all interested parties to review the presentations and materials below and to provide feedback on the content, recommendations, and process for evaluation for the topics presented. If you wish to submit any feedback, please fill out the form below. Feedback that is received will be reviewed and considered prior to the finalization of STIC recommendations. We also welcome suggestions about potential pathogen/drug combinations for future evaluation.
USCAST values the input from participants of the virtual meeting, our community, and the public. We look forward to hearing from you!
These USCAST STIC recommendations are now open for public comment for the next 60 days. This open public comment period will end on April 30, 2023.
USCAST encourages all interested parties to review the presentations and materials below and to provide feedback on the content, recommendations, and process for evaluation for the topics presented. If you wish to submit any feedback, please fill out the form below. Feedback that is received will be reviewed and considered prior to the finalization of STIC recommendations. We also welcome suggestions about potential pathogen/drug combinations for future evaluation.
USCAST values the input from participants of the virtual meeting, our community, and the public. We look forward to hearing from you!
|
|
Piperacillin/tazobactam breakpoints: Enterobacterales and P. aeruginosa Thomas Lodise, PharmD Executive Committee, USCAST Download Slides |
|
|
|
|
|
|
|
|
Under Construction: We’re currently updating the USCAST website, so some content is not current.